CoChat

Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)

Open access

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index; 5 of the 23 sources its claims cite were checked for support.

Abstract

OBJECTIVE: In women with gestational diabetes mellitus, who were randomized to metformin or insulin treatment, pregnancy outcomes were similar (Metformin in Gestational diabetes [MiG] trial). Metformin crosses the placenta, so it is important to assess potential effects on growth of the children. RESEARCH DESIGN AND METHODS: In Auckland, New Zealand, and Adelaide, Australia, women who had participated in the MiG trial were reviewed when their children were 2 years old. Body composition was measured in 154 and 164 children whose mothers had been randomized to metformin and insulin, respectively. Children were assessed with anthropometry, bioimpedance, and dual energy X-ray absorptiometry (DEXA), using standard methods. RESULTS: The children were similar for baseline maternal characteristics and pregnancy outcomes. In the metformin group, compared with the insulin group, children had larger mid-upper arm circumferences (17.2 ± 1.5 vs. 16.7 ± 1.5 cm; P = 0.002) and subscapular (6.3 ± 1.9 vs. 6.0 ± 1.7 mm; P = 0.02) and biceps skinfolds (6.03 ± 1.9 vs. 5.6 ± 1.7 mm; P = 0.04). Total fat mass and percentage body fat assessed by bioimpedance (n = 221) and DEXA (n = 114) were not different. CONCLUSIONS: Children exposed to metformin had larger measures of subcutaneous fat, but overall body fat was the same as in children whose mothers were treated with insulin alone. Further follow-up is required to examine whether these findings persist into later life and whether children exposed to metformin will develop less visceral fat and be more insulin sensitive. If so, this would have significant implications for the current pandemic of diabetes.

Overview

CoChat Summary

TL;DR

In 2-year-old offspring of women with gestational diabetes randomized to metformin or insulin in the MiG trial, metformin-exposed children had larger upper-arm circumference and biceps/subscapular skinfolds, but no difference in total or percentage body fat by DEXA or bioimpedance. The authors conclude the findings are reassuring but that longer follow-up is needed to assess visceral fat and insulin sensitivity.

Key findings

  • Among 318 children assessed at age 2 years (154 metformin, 164 insulin), the metformin group had larger mid-upper arm circumference (17.2 ± 1.5 vs. 16.7 ± 1.5 cm; P = 0.002), subscapular skinfold (6.3 ± 1.9 vs. 6.0 ± 1.7 mm; P = 0.02), and biceps skinfold (6.03 ± 1.9 vs. 5.6 ± 1.7 mm; P = 0.04); adjusted P values were 0.005, 0.01, and 0.02, respectively.
  • DEXA measures (n = 114; 57 per arm) showed no differences in total fat (2,421 ± 1,002 vs. 2,274 ± 711 g; P = 0.37), abdominal fat (132 ± 73 vs. 131 ± 60 g; P = 0.92), abdominal-to-thigh fat ratio (0.48 ± 0.1 vs. 0.50 ± 0.1; P = 0.33), lean body mass, bone mineral content, FFM, or total fat percentage (16.4 ± 4.9 vs. 16.9 ± 4%; P = 0.34). Bioimpedance (n = 221) also showed no difference in FFM or percentage fat.
  • Baseline maternal characteristics and pregnancy outcomes were similar between follow-up groups, including the MiG primary composite of neonatal complications (31.2 vs. 34.7%; P = 0.97) and neonatal unit admission (17.5 vs. 18.3%; P = 0.97). Maternal bioimpedance at follow-up showed higher FFM in the metformin group (51.3 ± 9.21 vs. 48.5 ± 9.09 kg; P = 0.01), but total fat percentage was not different (40.1 ± 7.83 vs. 38.6 ± 7.35%; P = 0.11).

Methods

  • Follow-up of women from the MiG trial at Auckland, New Zealand, and Adelaide, Australia, when children were approximately 2 years old; 323 women were seen, and body composition measurements were performed in 318 children (154 metformin, 164 insulin). Assessments included anthropometry, bioimpedance analysis, and DEXA; diet, activity, and neurodevelopmental findings were reported separately.
  • Continuous variables were normally distributed and presented as mean ± SD; one-way ANOVA and post hoc t tests were used, with significance at 5%. ANCOVA adjusted for height, weight, and age when examining fat mass and FFM among ethnic groups; additional analyses adjusted for age, sex, ethnicity, and maternal glucose control. Power calculations indicated 240 children (120 per arm) would detect a 2% difference in body fat percent with 97% power, and 37 children per arm would have 80% power.
  • DEXA whole-body scans were performed on a Lunar Prodigy 2000 scanner; scans graded 3 for poor quality were excluded. Abdominal and thigh regions of interest were defined by the criteria of Ley et al. A bioimpedance FFM prediction equation was developed using DEXA FFM as the criterion.

Limitations

  • Stated: the follow-up rate of the total MiG cohort was low. The follow-up group had fewer Polynesian children (14 vs. 20%; P = 0.02), shorter crown-rump length at birth (33.0 vs. 33.5 cm; P = 0.005), and smaller triceps skinfolds (4.80 vs. 5.15 mm; P = 0.0002) and subscapular skinfolds (4.95 vs. 5.20 mm; P = 0.07) at birth than the total group; otherwise they were representative and the study was adequately powered.
  • Stated: central fat measures combined subcutaneous and visceral fat, so further studies are needed to confirm whether metformin-exposed children have less visceral fat. The authors also note there are no other similar studies for comparison and that further follow-up is required to see whether differences persist and to measure visceral/subcutaneous fat and insulin sensitivity.
  • Evident from the text: DEXA analysis included only 114 of 318 children (57 per arm) after excluding poor-quality scans, and bioimpedance was performed in 221 children, so body-composition subsamples were smaller than the full follow-up cohort.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2337/dc11-0660

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Figure 1 Offspring followed up from the MiG trial.
Figure 1 Offspring followed up from the MiG trial.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 10 Not checked · 32 Own results and interpretations

22 more claims

Create a free account to see all 46 claims and to verify the 18 references still open.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 1

  1. Bristow S. Associations of patterns of daily life, physical fitness and body composition of primary age school children [MPhil thesis online], 2010. Auckland University of Technology. Available from http://aut.researchgateway.ac.nz/handle/10292/1010. Accessed 25 August 2011

Cited by

Metadata

Authors
Rowan, J. A., Rush, E. C., Obolonkin, V., Battin, M., Wouldes, T., & Hague, W. M.
Affiliations
  • Department of Obstetrics, National Women’s Health, Auckland, New Zealand
  • Auckland University of Technology (NZ)
  • University of Auckland (NZ)
  • Department of Pediatrics, National Women’s Health, Auckland, New Zealand
  • Women's and Children's Hospital (AU)
Corresponding author
Rowan, Janet A.
Venue
Diabetes Care
Published
2011-09-15
Volume
34
Issue
10
Pages
2279-2284
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2102307174
Cited by
379
References
24
Citations by year
2026: 14 · 2025: 16 · 2024: 16 · 2023: 22 · 2022: 25 · 2021: 36 · 2020: 26 · 2019: 27 · 2018: 50 · 2017: 19 · 2016: 31 · 2015: 28 · 2014: 22 · 2013: 28 · 2012: 16
FWCI
28.83
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Tuwhera (Auckland University of Technology) (submittedVersion, cc-by-nc-nd)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
  • ResearchSpace (University of Auckland) (submittedVersion, cc-by)
Funders
  • Auckland University of Technology, New Zealand
  • University of Adelaide
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
metformin, gestational diabetes mellitus, insulin therapy, offspring body composition, subcutaneous adipose tissue, fat mass, child growth, prenatal drug exposure, diabetes prevention
MeSH terms
Anthropometry, Body Composition, Child, Preschool, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Insulin, Male, Metformin, Pregnancy, Prenatal Exposure Delayed Effects, Absorptiometry, Photon, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.